bridge7

bridge7 exists to meet the global need for world class cancer care by providing on-demand consultation and expert insights. Our clinically validated machine learning algorithms enable clinical teams to gain instant consultation and insights on the quality of cancer care before patients begin their treatment course. The platform allows hospitals to increase clinical efficiency, improve quality, and enable delivery of cancer care at the same level as leading hospitals around the world.

 

 

Team Members

Meir Dick
CEO

Chris McInrosh
CML

Tom Purdie
CCO

Robert Fenwick
Business Development